學位

國防醫學院醫學系醫學士
國防醫學院醫學科學研究所博士

經歷

國防醫學院 病理及寄生蟲研究所 所長
三軍總醫院 病理部 部主任
三軍總醫院病理部 主治醫師
三軍總醫院病理部 住院總醫師
三軍總醫院病理部 住院醫師

專長學科

1. 腎臟病變的診斷與致病機轉的探討
2. 子宮頸癌、子宮內膜癌及卵巢癌致病機轉的探討
3. 人工智慧於病理診斷的應用

獲獎情形

◎109年度醫學系優良總區段長

◎110年度醫學系優良總區段長

◎111年度醫學系優良總區段長

◎112年度醫學系優良總區段長

相關著作

1. Lin YJ, Chao TK, Khalil MA, Lee YC, Hong DZ, Wu JJ, Wang CW. Deep Learning Fast Screening Approach on Cytological Whole Slides for Thyroid Cancer Diagnosis. Cancers (Basel). 2021 Aug 2;13(15):3891.
2. Hsu PC, Chao TK, Chou YC, Yu MH, Wang YC, Lin YH, Lee YL, Liu LC, Chang CC. AIM2 Inflammasome in Tumor Cells as a Biomarker for Predicting the Treatment Response to Antiangiogenic Therapy in Epithelial Ovarian Cancer Patients. J Clin Med. 2021 Sep 30;10(19):4529.
3. Wang CW, Liou YA, Lin YJ, Chang CC, Chu PH, Lee YC, Wang CH, Chao TK. Artificial intelligence-assisted fast screening cervical high grade squamous intraepithelial lesion and squamous cell carcinoma diagnosis and treatment planning. Sci Rep. 2021 Aug 10;11(1):16244
4. Liu NT, Perng CL, Chou YC, Ko PS, Lin YJ, Lin YC, Chang CC, Wang YC, Shang HS, Chao TK. Loss of ten-eleven translocation 1 (TET1) expression as a diagnostic and prognostic biomarker of endometrial carcinoma. PLoS One. 2021 Nov 3;16(11):e0259330. 
5. Huang YS, Lu KC, Chao HW, Chen A, Chao TK, Guo CY, Hsieh HY, Shih HM, Sytwu HK, Wu CC. The MTNR1A mRNA is stabilized by the cytoplasmic hnRNPL in renal tubular cells. J Cell Physiol. 2021 Mar;236(3):2023-2035. 
6. Su PH, Hsu YW, Huang RL, Chen LY, Chao TK, Liao CC, Chen CW, Wu TI, Mao SP, Balch C, Lai HC. TET1 promotes 5hmC-dependent stemness, and inhibits a 5hmC-independent epithelial-mesenchymal transition, in cervical precancerous lesions. Cancer Lett. 2019 May 28;450:53-62. 
7. Chen LY, Huang RL, Chan MW, Yan PS, Huang TS, Wu RC, Suryo Rahmanto Y, Su PH, Weng YC, Chou JL, Chao TK, Wang YC, Shih IM, Lai HC. TET1 reprograms the epithelial ovarian cancer epigenome and reveals casein kinase 2α as a therapeutic target. J Pathol. 2019 Jul;248(3):363-376.
8. Lai YJ, Chou YC, Lin YJ, Yu MH, Ou YC, Chu PW, Wu CC, Wang YC, Chao TK. Pyruvate Kinase M2 Expression: A Potential Metabolic Biomarker to Differentiate Endometrial Precancer and Cancer That Is Associated with Poor Outcomes in Endometrial Carcinoma. Int J Environ Res Public Health.
9. Tzeng SF, Tsai CH, Chao TK, Chou YC, Yang YC, Tsai MH, Cha TL, Hsiao PW. O-Glycosylation-mediated signaling circuit drives metastatic castration-resistant prostate cancer. FASEB J. 2018 Jun 15:fj201800687.
10. Huang RL, Chen HJ, Chen LY, Chao TK, Lin WY, Liew PL, Su PH, Weng YC, Wang YC, Liao CC, Hsu YW, Wang HC, Lai HC. Epigenetic loss of heparan sulfate 3-O-sulfation sensitizes ovarian carcinoma to oncogenic signals and predicts prognosis. Int J Cancer. 2018 Oct 15;143(8):1943-1953.
11. Chao TK, Huang TS, Liao YP, Huang RL, Su PH, Shen HY, Lai HC, Wang YC. Pyruvate kinase M2 is a poor prognostic marker of and a therapeutic target in ovarian cancer. PLoS One. 2017 Jul 28;12(7):e0182166.